Determination of 8-methoxypsoralen in human plasma, and microdialysates using liquid chromatography-tandem mass spectrometry.

[1]  R. Kaufmann,et al.  Time course of 8‐methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8‐methoxypsoralen , 2002, Clinical pharmacology and therapeutics.

[2]  T. Zollner,et al.  Kinetics and dose–response of photosensitivity in cream psoralen plus ultraviolet A photochemotherapy: comparative in vivo studies after topical application of three standard preparations , 2001, The British journal of dermatology.

[3]  T. Zollner,et al.  Cream PUVA therapy for scleredema adultorum , 2000, The British journal of dermatology.

[4]  U. Yeo,et al.  Psoralen‐ultraviolet A‐induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid , 2000, The British journal of dermatology.

[5]  B. Berne,et al.  PUVA and cancer risk: the Swedish follow‐up study , 1999, The British journal of dermatology.

[6]  M. Kerscher,et al.  Treatment of severe recalcitrant dermatoses of the palms and soles with PUVA‐bath versus PUVA‐cream therapy , 1999, Photodermatology, photoimmunology & photomedicine.

[7]  J. Lötsch,et al.  Application of microdialysis for the determination of muscle and subcutaneous tissue concentrations after oral and topical ibuprofen administration , 1999, Clinical pharmacology and therapeutics.

[8]  M. Kerscher,et al.  Plasma levels of 8‐methoxypsoralen following PUVA‐bath photochemotherapy , 1998, Photodermatology, photoimmunology & photomedicine.

[9]  G. Plewig,et al.  Psoralen bath plus UV-A therapy. Possibilities and limitations. , 1997, Archives of dermatology.

[10]  H. Eichler,et al.  Diclofenac concentrations in defined tissue layers after topical administration , 1997, Clinical pharmacology and therapeutics.

[11]  M. Schmelz,et al.  Plasma extravasation and neuropeptide release in human skin as measured by intradermal microdialysis , 1997, Neuroscience Letters.

[12]  R. Stern,et al.  Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study. , 1997, The New England journal of medicine.

[13]  L. Petersen,et al.  Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[14]  I. Arranz,et al.  Plasma levels of 8‐methoxypsoralen after bath‐PUVA for psoriasis: relationship to disease severity , 1995, The British journal of dermatology.

[15]  W. Westerhof,et al.  A new psoralen‐containing gel for topical PUVA therapy: development, and treatment results in patients with palmoplantar and plaque‐type psoriasis, and hyperkeratotic eczema , 1995, The British journal of dermatology.

[16]  Christopher M. Riley,et al.  Microdialysis Sampling for the Investigation of Dermal Drug Transport , 1992, Pharmaceutical Research.

[17]  F. Zacchello,et al.  Determination of 8-methoxypsoralen in plasma by gas chromatography-mass spectrometry using selected-ion monitoring. , 1992, Journal of chromatography.

[18]  U. Ungerstedt,et al.  Microdialysis—principles and applications for studies in animals and man , 1991, Journal of internal medicine.

[19]  S. E. Thomas,et al.  Plasma levels of 8‐methoxypsoralen following oral or bath‐water treatment , 1991, The British journal of dermatology.

[20]  C. A. Robinson,et al.  Analysis of 8-methoxypsoralen by high-performance liquid chromatography. , 1990, Clinical chemistry.

[21]  H. Reinauer,et al.  High-performance liquid chromatographic measurement of 8-methoxypsoralen in plasma , 1986 .

[22]  D. P. Goldstein,et al.  Minimal phototoxic doses and 8-MOP plasma levels in PUVA patients. , 1982, The Journal of investigative dermatology.

[23]  M. Schemper,et al.  Skin tumors in photochemotherapy for psoriasis: a single-center follow-up of 496 patients. , 1996, Dermatology.

[24]  F. Wolff,et al.  Clinical Pharmacokinetics of Methoxsalen and Other Psoralens , 1986, Clinical pharmacokinetics.

[25]  D. Carter,et al.  Plasma levels of 8-methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers. , 1980, The Journal of investigative dermatology.

[26]  Thomas B. Fitzpatrick,et al.  Dermatology in general medicine , 1971 .